-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

Benzinga·02/09/2026 12:31:21
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $8 price target.